ARA-290 is a synthetic peptide derived from erythropoietin (EPO), designed to activate tissue-protective pathways without stimulating red blood cell production.
This targeted analog is known for its neuroprotective and anti-inflammatory effects, offering potential benefits in neuropathic pain, tissue repair, and autoimmune modulation.
ARA-290 plays a key role in promoting vascular repair, reducing nerve inflammation, and improving microcirculation, particularly in conditions involving chronic pain or nerve damage.
In addition to supporting nerve health, ARA-290 enhances tissue resilience and regeneration, making it valuable for studies in diabetes-related complications and inflammatory diseases.
Ideal for research focused on pain modulation, immune balance, and tissue protection, ARA-290 is a unique compound with promising regenerative and therapeutic potential.